NOW A FULL-SERVICE CRO
DELIVERING END-TO-END SUPPORT FOR DRUG, BIOTECH & MEDICAL DEVICE INNOVATORS.
NOW A FULL-SERVICE CRO
DELIVERING END-TO-END SUPPORT FOR DRUG, BIOTECH & MEDICAL DEVICE INNOVATORS.
Integrated Clinical and Regulatory Expertise for Accelerated Therapeutic & Medical Device Success
As a full-service Contract Research Organisation (CRO), we deliver end-to-end support for medical device innovators drug and biotech companies — providing regulatory strategic planning, comprehensive clinical trial execution, regulatory and medical writing, and robust quality assurance from early development through market submission.
We specialize in partnering with start-ups and small to mid-sized drug and biotech companies that require seasoned external resources to navigate complex clinical and regulatory pathways.
Our extensive expertise in global regulatory and GCP requirements enables us to conduct high-quality clinical studies across a broad range of therapeutic areas, including addiction, analgesics, anti-inflammatory, cardiovascular, endocrinology, gastroenterology, neurology, oncology, pediatric and adult rare diseases, women’s health, and vaccines.
OUR SERVICES
Whether you require support for a specific study component or a full-service partner from early development through regulatory authorization submissions (FDA, Health Canada, EMA, PMDA), our services scale to meet your program’s needs.
WHO WE ARE
EXPERTISE THAT MOVES PROGRAMS FORWARD
LBRIA THE MERGER SUCCESS STORY
TALK TO US TODAY
Whether you are a start-up preparing for your first regulatory submission, an established organization seeking to augment internal capabilities, an international company requiring an FDA Authorized Representative, or an investor or legal professional seeking independent regulatory and clinical expertise, LBRIA is positioned to support your needs. Contact us today to discuss how we can help advance your program.